CSIMarket
 
Neurocrine Biosciences Inc   (NASDAQ: NBIX)
 

Neurocrine Biosciences Inc's Suppliers Performance

NBIX's Supply Chain




 
NBIX Costs vs Sales of Suppliers Growth Neurocrine Biosciences Inc recorded an increase in cost of sales by 125.24 % year on year, sequentially cost of sales grew by 68.12 % in Q2.

• More on NBIX Suppliers



Neurocrine Biosciences Inc recorded increase in cost of sales by 125.24 % year on year, sequentially cost of sales grew by 68.12 % in Q2.

• More on NBIX Suppliers




Neurocrine Biosciences Inc's Comment on Supply Chain


The company sources raw materials, active pharmaceutical ingredients (API), and other supplies for the production of INGREZZA, CRENESSITY, and product candidates from various third-party manufacturers and suppliers. Supply is maintained through long-term commercial supply and manufacturing agreements with multiple manufacturers. The company focuses on expanding and diversifying its third-party manufacturing relationships. It relies on third-party partners and quality system oversight to ensure compliance with current Good Manufacturing Practice (cGMP) requirements and applicable foreign standards.

Neurocrine Biosciences Inc's Comment on Supply Chain


The company sources raw materials, active pharmaceutical ingredients (API), and other supplies for the production of INGREZZA, CRENESSITY, and product candidates from various third-party manufacturers and suppliers. Supply is maintained through long-term commercial supply and manufacturing agreements with multiple manufacturers. The company focuses on expanding and diversifying its third-party manufacturing relationships. It relies on third-party partners and quality system oversight to ensure compliance with current Good Manufacturing Practice (cGMP) requirements and applicable foreign standards.







NBIX's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Neurocrine Biosciences Inc 14,421.28 3,373.90 705.50 2,000
SUBTOTAL 0.00 0.00 0.00 -


Sources: Neurocrine Biosciences Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Neurocrine Biosciences Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.